全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

CNKI中乙肝肝硬化高被引文献的计量分析
A Quantitative Analysis of High Citation Frequency of Hepatitis B Cirrhosis in CNKI

DOI: 10.12677/ACM.2020.109314, PP. 2095-2101

Keywords: 乙肝肝硬化,CNKI,高被引,文献计量学
Hepatitis B cirrhosis
, CNKI, Highly Cited, Bibliometric Science

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:分析我国乙肝肝硬化高被引文献的计量特征。方法:检索中国学术期刊全文数据库(CNKI)不限年份的乙肝肝硬化文献,参照普赖斯定律确定高被引文献,用Excel 2007统计分析被引、年份、期刊、作者、单位、关键词、基金。结果:检出高被引文献145篇,累计被引1887次,篇均被引13.01次。文献数自2011年开始曲线上升至2015年达峰值27篇,之后迅速下降;文献分布在97种期刊。文献作者共120人、署名132次,总合作率68.27%;作者机构156个,其中医院占62.82%,5个核心发文机构中院校占60.00%。涉及关键词231个、566次。29篇文献获基金32项次,其中省部级以上基金占53.13%。结论:乙肝肝硬化领域的相关研究仍值得关注,需形成乙肝肝硬化研究的核心团队,加大资助资金。预测未来将围绕乙肝肝硬化患者的管理、干预等方面继续深入地探究。
Objective: To analyze the metrological characteristics of Chinese literature with high citation frequency of hepatitis B cirrhosis. Methods: We searched Chinese Academic Journal FULL-text Database (CNKI) literature on hepatitis B cirrhosis of unlimited years, determined the cited references with high citation frequency by referring to Price’s law, and analyzed the frequency and years of being cited, the cited journals, authors and institutions, keywords, and grants with Excel 2007 statistical analysis. Results: There were 145 cited references with high citation frequency, which were cited 1,887 times in total and mean 13.01 times each. The number of literatures began to rise from 2011 to the peak of 27 articles in 2015, and then fell rapidly. Articles are distributed in 97 different journals. In total, 120 authors signed 132 times, with a total cooperation rate of 68.27%; authors from 156 institutions, including hospitals accounted for 62.82%, and academies and universities accounted for 60.00% of the 5 key institutions. There were 231 keywords and 566 times. Twenty-nine papers received 32 funds, of which 53.13 were funds at or above the provincial and ministerial level. Conclusion: Relevant studies in the field of Hepatitis B cirrhosis are still worthy of attention and a core team for the study of hepatitis B cirrhosis should be formed. The future prediction of increased funding will be further explored in terms of management intervention for patients with hepatitis B cirrhosis.

References

[1]  Ashhab, A.A., Rodin, H., Campos, M., et al. (2020) Response to Hepatitis B Virus Vaccination in Individuals with Chronic Hepatitis C Virus Infection. PLoS ONE, 15, e0237398.
https://doi.org/10.1371/journal.pone.0237398
[2]  刘步平, 孙锋, 林亮, 等. CNKI中前列腺炎高被引文献的计量分析[J]. 中华男科学杂志, 2014, 20(10): 943-948.
[3]  王凤英, 曹松, 于德军, 王淑艳, 徐志峰. 检测慢性乙肝及乙肝肝硬化患者血小板功能的意义[J]. 临床肝胆病杂志, 2002(3): 175-176.
[4]  王晓晗. 益气解毒通络方治疗乙肝肝硬化有效性及其控制癌变的研究[J]. 智慧健康, 2020, 6(17): 154-155.
[5]  World Health Organization (2017) Global Hepatitis Report 2017. World Health Organization.
https://apps.who.int/iris/handle/10665/255016
[6]  Guan, X., Xing, F. and Li, Y. (2020) Alcohol Consumption Increases the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B Cirrhosis But Not in Patients with Hepatitis C Cirrhosis. European Journal of Gastroenterology & Hepatology, 10, 1097.
https://doi.org/10.1097/MEG.0000000000001837
[7]  黄拼搏, 胡志刚, 许侨东, 颜永聪, 王捷. ALPPS在具有乙肝肝硬化背景的巨块型肝癌中的应用[J]. 岭南现代临床外科, 2015, 15(5): 527-532.
[8]  赵蔚, 张英. HBeAg阴性和阳性乙肝肝硬化患者血常规, 肝功能, HBVDNA, Child-Pugh分级对比分析[J]. 山西医科大学学报, 2014, 45(8): 736-739.
[9]  常桂彬, 郑玉宝. 乙肝肝硬化患者抑郁情绪与肝硬化病情严重程度的相关性[J]. 热带医学杂志, 2014, 14(7): 871-873+896.
[10]  周小军, 孟晓军, 林子玲, 宋家武, 边壮, 郭惠学. 疏肝健脾法联合拉米夫定治疗乙肝肝硬化的临床疗效观察[J]. 中药材, 2011, 34(10): 1639-1641.
[11]  杨宏志, 李春涛, 王拥泽, 关卫兵, 杨跃武. 清下消补法组方对乙肝肝硬化预后因素影响的临床观察[J]. 中药材, 2003(11): 841-843.
[12]  Zhang, T., Yang, Y., Wang, B., et al. (2019) Meta-Analysis of Influences of Biejiajian Pill Combined with Entecavir on Serum Liver Fibrosis Markers of Compensatory Period of Hepatitis B Cirrhosis: Protocol of Systematic Review and Meta-Analysis. Medicine, 98, e18458.
https://doi.org/10.1097/MD.0000000000018458

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133